Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Intravenous Bolus Norepinephrine 4 mcg vs Placebo for Prevention of Spinal Hypotension in Hypertensive Disorders of Pregnancy During Cesarean Section
TCTR20260217006Phase 4Not yet recruiting
- Sponsor
- Chaophrayayommarat Hospital
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of norepinephrine in hypotension induced by spinal anesthesia, maternal hypertension (HDP), sponsored by Chaophrayayommarat Hospital. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
norepinephrine
03
Conditions
hypotension induced by spinal anesthesiamaternal hypertension (HDP)
Beyond the preview
Go deeper on TCTR20260217006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260217006.